Alkermes plc (NASDAQ:ALKS) Q3 2023 Results Earnings Conference Call October 25, 2023 8:00 AM ET
Company Participants
Sandra Coombs - Senior Vice President, Corporate Affairs and Investor Relations
Iain Brown - Senior Vice President and Chief Financial Officer
Todd Nichols - Senior Vice President and Chief Commercial Officer
Craig Hopkinson - Executive Vice President, Research & Development and Chief Medical Officer
Richard Pops - Chairman and Chief Executive Officer
Conference Call Participants
Amy Li - Jefferies
David Amsellem - Piper Sandler
Umer Raffat - Evercore ISI
Paul Matteis - Stifel
Chris Shibutani - Goldman Sachs
Jason Gerberry - Bank of America
Marc Goodman - Leerink Partners
Uy Ear - Mizuho Securities
Douglas Tsao - H.C. Wainwright
Ashwani Verma - UBS
Charles Duncan - Cantor Fitzgerald
Operator
Greetings. And welcome to the Alkermes Third Quarter 2023 Financial Results Conference Call. My name is Donna and I’ll be your operator for today’s call. All participant lines will be placed on mute to prevent background noise. [Operator Instructions] Please note that this conference is being recorded.
I’ll now turn the call over to Sandy Coombs, Senior Vice President of Investor Relations and Corporate Affairs. Thank you, Sandy. You may now begin.
Sandra Coombs
Good morning. Welcome to the Alkermes plc conference call to discuss our financial results and business update for the quarter ended September 30, 2023, as well as initial clinical data related to ALKS 2680 presented during this week's World Sleep meeting.
With me today are Richard Pops, our CEO; Iain Brown, our CFO; Todd Nichols, our Chief Commercial Officer; and Dr. Craig Hopkinson, our Chief Medical Officer.
During today's call, we will be referencing slides which are available on the Investor Events section of our website. Additionally, I encourage everyone to go to the Investor section of the alkermes.com to find our press release, related financial tables and reconciliations of the GAAP to non-GAAP financial measures that we'll discuss today.
We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business.
Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see slide 2 of the accompanying presentation, our press release issued this morning and our most recent annual and quarterly reports filed with the SEC for important risk factors that could cause our actual results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise the information provided on this call or in the accompanying presentation as a result of new information or future results or developments.